Click Here
Diabetes Mall Logo

Meters & Monitors


Blood Glucose Meters Next Current Continuous Monitors Next Comparison of Available Monitors Next
Various Future Monitors Next Improving Today's Meters Next Other Monitors Next Older Monitors

Future Monitoring

AiMedics Next A.Menarini Diagnostics Next Cybiocare OHD Next InLight Solutions Next Kumetrix Next LighTouch Medical Next NAS - iSense Next NIR Diagnostics Next Optiscan Next Orsense Next Pindi Products Next Sensors For Medicine and Science Next Sensys Medical Next Sentek Next Solianis Next Sontra Next SpectRx Next Synthetic Blood International Next Therasense Next Visual Pathways

InLight Solutions - Near Infrared Technology Non-Invasive

InLight Solutions researches and develops sensor-based measurement systems for life science applications. They have ties with researchers at the University of New Mexico, and has been working on a Near-IR device for several years. InLight's optics and software design is specific to distinguish the target molecule glucose, from similar molecules like water.

Their devices consist of three parts: a light source, an optical detector, and a spectrometer. The light shines into the skin and a small amount of that light reflects back. The reflected light is analyzed by the spectrometer with subsequent measurement by the detector. Measuring the differences between the light that went into the skin with the light that the detector collects. Each molecule's response to the light can be distinguished by different vibration characteristics, thus the system can be programmed to analyze a particular molecule. This system is optimized to give an accurate quantitative measurement of glucose concentrations in the body.

Veralight's Scout DS
VeraLight, Inc. was established in 2004 as a spinout of Inlight Solutions to focus on a comprehensive approach to noninvasive diabetes screening. They are developing the Scout DS instrument for screening of type 2 and pre-diabetes. Scout DS employs fluorescence spectroscopy to noninvasively measure advanced glycation endproducts (AGEs) in the skin of a subject’s forearm. Skin AGEs are a well-known biomarker of diabetes, an excellent indicator of cumulative hyperglycemic exposure, and have been shown to predict the development of type 2 diabetes.


Click Here to browse our secure, on-line store for a complete selection of diabetes books at 22%-50% off their cover price. You can also download our Diabetes Mall 2008 Catalog, email our Order Form, or call us at (800) 988-4772.

Back to Top top